单核细胞趋化蛋白-1在泌尿系肿瘤中作用的研究进展
摘要
本文综述了MCP-1与肿瘤多耐药性、肿瘤转移之间的关系,特别是MCP-1与泌尿系肿瘤之间的关系,包括肾脏的特异性转移,膀胱的分期、分级,以及BCG治疗浅表性膀胱肿瘤与MCP-1相关的研究进展。
出处
《现代泌尿外科杂志》
CAS
2000年第4期243-245,248,共4页
Journal of Modern Urology
参考文献9
-
1Huang S, Xie K, Singh PK, et al. Suppression of tumur growth and metastasis of murine renal adenocarcinomar by syngeneic fibroblasts genetically engineered to secrete the JE/mcp-1 Cytokine, J Interferon cytokine Res, 1995 ; 15 (7) :655-665.
-
2Hamada H, and Tsuruo T. Purification of the 170-to 180-kilodalton membrance glycoproteion associated with multidrug-resistance. J Boil,Chem, 1998;263:1454-1458.
-
3Holzmayer TA, Hilsenbeck S, Von hoff DD.Clinical correletes of MDR1 (P-glycoprotein)gene expression in ovarian and small-cell lung carcinomas. J net. Cancer Inst, 1992;84:1486-1491.
-
4Nokihara H, Nishioka Y, Yano S, et al. Monocyte chemoattractant protein-1 gene modification of muhidrug-resistant human lung cancer enhances antimetastatic effect of therapy with antip-glycoprotein antibody in SCID mice. Int J Cancer, 1999;80:773-780.
-
5Huang S, Singh RK, Xie K, et al. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cell. Cancer Immunol immunother, 1994; 39: 231-238.
-
6Nakashima E, Mukaida N, Kubota Y, et al.Humen MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo. Pharmacent Rest 1995;12:1598-1604.
-
7Yano S, Nishioka Y, Izumi K, et al. Novel metastasis model of human lung cancer in SCID mice depleted of NK cell. Int J Cancer, 1996;61:211-217.
-
8AMANN B, PERABO F. G. E, WINGER A, et al. Urinary levels of monocyte chmo-attractant protein-1 correlate with tumour stage and grade in patients with bladder cancer. Brit J Urology,1998;82:118-121.
-
9Iantorno R, Niccolai M, Cipollone G, et al.Role of MCP-1 chemokine in the response of monocytes with superficial tumors of the bladder treated with BCG immunotherapy. Arch Ital Urol Androl, 1997;69(suppl 1):71-72.
-
1李杜渐,陈一戎.单核细胞趋化蛋白-1在泌尿系肿瘤中作用的研究进展[J].国外医学（泌尿系统分册）,2001,21(2):83-83.
-
2徐勇,张文颖,马腾骧.FN介导BCG治疗膀胱肿瘤的研究进展[J].国外医学（泌尿系统分册）,1996,16(1):4-6.
-
3顾寿智,杨佩满.肿瘤细胞多耐药性的研究进展[J].大连医学院学报,1992,14(2):72-76.
-
4周秀苹.多耐药性肿瘤细胞系的细胞遗传学研究[J].锦州医学院学报,1994,15(4):7-11.
-
5郑超.膀胱灌注BCG治疗膀胱癌的42例体会[J].锦州医学院学报,2005,26(4):90-90.
-
6贺大林.BCG治疗膀胱癌的研究进展[J].国外医学（泌尿系统分册）,1998,18(2):70-71. 被引量：1
-
7苏雷,魏秀芹.肺癌多耐药性研究进展及基因治疗[J].国外医学（肿瘤学分册）,2002,29(6):429-432. 被引量：3
-
8蒋云仙,王克孝,邢江湜,于德新,刘明,饶慧蓉,汪发贵.BCG治疗膀胱颈口肿瘤的疗效观察[J].安徽医科大学学报,1992,27(3):219-220.
-
9李志风,何舜发.非肌层浸润性膀胱癌使用BCG治疗失败后的治疗[J].泌尿外科杂志（电子版）,2015,7(4):4-6.
-
10刘静,郭华雄.趋化因子CXCL12/CXCR4生物轴在肿瘤中的研究进展[J].临床与实验病理学杂志,2010,26(4):477-480. 被引量：13
